Protara Therapeutics, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Protara Therapeutics, Inc. (TARA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $1.45 per share for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2018-03-14
- Protara Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2017-03-31 was $1.45, a 24.48% decline year-over-year.
- Protara Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2016-03-31 was $1.92, a 51.18% increase year-over-year.
- Protara Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2015-03-31 was $1.27.
- Protara Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2017 was $1.45, a 27.86% decline from fiscal 2016.
- Protara Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2016 was $2.01, a 2.55% increase from fiscal 2015.
- Protara Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2015 was $1.96, a 3.70% increase from fiscal 2014.
- Protara Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2014 was $1.89.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2017-12-31 | $1.45 10-K · filed 2018-03-14 | |||
| 2017-06-30 | $1.45 10-Q · filed 2017-08-07 | |||
| 2017-03-31 | $1.45 10-Q · filed 2017-05-10 | |||
| 2016-12-31 | $2.01 10-K · filed 2017-03-16 | |||
| 2016-09-30 | $1.91 10-Q · filed 2016-11-07 | |||
| 2016-06-30 | $1.91 10-Q · filed 2016-08-08 | |||
| 2016-03-31 | $1.92 10-Q · filed 2016-05-09 | |||
| 2015-12-31 | $1.96 10-K · filed 2016-03-14 | |||
| 2015-06-30 | $1.83 10-Q · filed 2015-08-13 | |||
| 2015-03-31 | $1.27 10-Q · filed 2015-05-13 | |||
| 2014-12-31 | $1.89 10-K · filed 2015-03-20 | |||
| 2014-09-30 | $1.27 10-Q · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |